quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 26, 2026

Directed Energy Weapons Research Report 2026: $32.53 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts | Astute Analytica

View original at globenewswire.com
Directed Energy Weapons Research Report 2026: $32.53 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts | Astute Analytica Chicago, Jan…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • High Energy Laser (HEL) technology captures more than 58% of the DEW market share

    80% confidence
  • China follows with a $1.8 billion investment, primarily concentrating on high-power microwave weapons

    80% confidence
  • India's DURGA II initiative targets a 100-kilowatt laser weapon for deployment across land, sea, and air platforms

    80% confidence
  • The United States leads DEW development, allocating $2.3 billion in 2025 for research and development

    80% confidence
  • The DEW market is growing at a CAGR of 18.60% from 2025 to 2033

    80% confidence
  • Asia Pacific could contribute up to $32.1 billion of the global directed energy weapons market by 2033

    80% confidence
  • Lethal directed energy weapons account for more than 60% of the revenue share

    80% confidence
  • Russia's upgraded Peresvet laser system now boasts an engagement range of up to 10 kilometers

    80% confidence
  • Japan has allocated $100 million to deploy 150 DEW systems over the next five years

    80% confidence
  • The global directed energy weapons market was valued at $7.11 billion in 2024 and is expected to reach $32.53 billion by 2033

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Directed Energy Weapons Research Report 2026: $32.53 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts | Astute Analytica — Source | Via News | pt.VIA.NEWS